Health Canada Drug Brand Name SafetyTesting
With the release of a guidance from Health Canada (HC) in June 2015 pertaining to preventing medication errors with drug brand names, market authorization holders must now follow a specific process to “safety test” their names, and submit their results to HC for review and approval. Click here to review the Health Candada guidance document.
Med-ERRS has developed a method to correspond to each part of the guidance from the initial questions to writing a final report for the brand name that you want to submit. Below is a diagram of the process we have developed: